Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Aaron Brzezinski, MD, was born in Mexico City and attended medical school at the Universidad Nacional Autonoma de Mexico, receiving his degree in medicine in 1981. He performed his postgraduate training in internal medicine at Hospital Espanol in Mexico City. Dr. Brzezinski moved to Toronto, Canada, to continue training with a residency in internal medicine and a fellowship in gastroenterology. He performed research for one year with Dr. Nicholas Diamant, and completed a special fellowship in inflammatory bowel disease and performed clinical research under Dr. Kursheed Jeejeebhoy and Dr. Jeffrey Baker at the University of Toronto.
Dr. Brzezinski is certified in internal medicine and in Gastroenterology in Canada and the United States, and in 1992 started to work in the Department of Gastroenterology and Hepatology at Cleveland Clinic as Assistant Staff. In 1994, he became a Staff Gastroenterologist.
Through the years, Dr. Brzezinski has been either principal investigator or sub-investigator in numerous clinical trials and has published in peer-reviewed journals and written numerous book chapters. He has lectured extensively within the United States and internationally in Argentina, Brazil, Chile, Dominican Republic, Ecuador, Guatemala, Mexico, Spain and Turkey.
Dr. Brzezinski actively participates in teaching medical students, residents and fellows. His clinical practice is almost exclusively in inflammatory bowel disease, microscopic colitis and celiac disease. Besides seeing patients in the office, he also performs upper endoscopy (EGD) and colonoscopy.
Celiac Disease, Crohn's Disease, IBD including Ulcerative Colitis and Crohn's, Inflammatory Bowel Disease, Ulcerative Colitis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/12/2015, Dr. Brzezinski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.